| | | Single nucleotide variant (3 prime UTR variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (missense variant) | not specified +5 more | |
| | | Deletion (frameshift variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +3 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (intron variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (missense variant) | Congenital myopathy 18 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Congenital myopathy 18 +4 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (intron variant) | Congenital myopathy 18 +4 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +5 more | |
| | | Single nucleotide variant (intron variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +3 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Congenital myopathy 18 +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Indel (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +5 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | Congenital myopathy 18 +3 more | |
| | | Single nucleotide variant (missense variant) | not specified +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia of anesthesia +7 more | |
| | | Single nucleotide variant (intron variant) | Congenital myopathy 18 +4 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (intron variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +3 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +5 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (intron variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (intron variant) | Congenital myopathy 18 +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Congenital myopathy 18 +4 more | |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Congenital myopathy 18 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Congenital myopathy 18 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +4 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +3 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (intron variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (intron variant) | Congenital myopathy 18 +4 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +3 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (intron variant) | not specified +5 more | |
| | | Inversion (intron variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +4 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Hypokalemic periodic paralysis, type 1 +4 more | |
| | | Single nucleotide variant (intron variant) | not specified +4 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (intron variant) | not specified +5 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +5 more | |
| | | Single nucleotide variant (intron variant) | not provided +4 more | |
| | | Single nucleotide variant (synonymous variant) | Hypokalemic periodic paralysis, type 1 +3 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 5 +4 more | |
| | | Single nucleotide variant (missense variant) | Congenital myopathy 18 +3 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 5 +3 more | |
| | | Single nucleotide variant (synonymous variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | Thyrotoxic periodic paralysis, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +4 more | |
| | | Single nucleotide variant (intron variant) | Congenital myopathy 18 +5 more | |
| | | Single nucleotide variant (intron variant) | Hypokalemic periodic paralysis, type 1 +4 more | |